Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages 1311-1319

  Taguchi, Ryo ^a   Yamada, Masanobu ^a   Nakajima, Yasuyo ^a   Satoh, Tetsurou ^a   Hashimoto, Koshi ^a   Shibusawa, Nobuyuki ^a   Ozawa, Atsushi ^a   Okada, Shuichi ^a   Rokutanda, Nana ^a   Takata, Daisuke ^a   Koibuchi, Yukio ^a   Horiguchi, Jun ^a   Oyama, Tetsunari ^a   Takeyoshi, Izumi ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CORTICOTROPIN; GLYCINE; MESSENGER RNA;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADULT; AGED; ALDOSTERONE PRODUCING ADENOMA; AMINO ACID SUBSTITUTION; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; DNA SEQUENCE; FEMALE; GENE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; JAPANESE; KCNJ5 GENE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOMATIC MUTATION;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; BASE SEQUENCE; CROSS-SECTIONAL STUDIES; CUSHING SYNDROME; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GENETIC ASSOCIATION STUDIES; HUMANS; HYPERALDOSTERONISM; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 84859378136     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2885     Document Type: Article

References (27)

1. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C 2008 Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371:1921-1926 (Pubitemid 351778191)
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:3266-3281
3. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050 (Pubitemid 38368386)
4. Rossi GP, Seccia TM, Pessina AC 2008 Primary aldosteronism. Part I: prevalence, screening, and selection of cases for adrenal vein sampling. J Nephrol 21:447-454
5. Young WF 2007 Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 66:607-618 (Pubitemid 46699525)
6. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
7. Nakajima Y, Yamada M, Taguchi R, Satoh T, Hashimoto K, Ozawa A, Shibusawa N, Okada S, Monden T, Mori M 2011 Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion. J Clin Endocrinol Metab 96:2512-2518
8. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-2300 (Pubitemid 44873058)
9. Stowasser M, Gordon RD 2003 Primary aldosteronism. Best Pract Res Clin Endocrinol Metab 17:591-605
10. Nishikawa T, Saito J, Omura M 2007 Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? Endocr J 54:487-495 (Pubitemid 47414594)
11. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2004 Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27:193-202 (Pubitemid 38489081)
12. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T 2006 Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29:883-889 (Pubitemid 46062119)
13. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP 2011 K+ Channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768-772
14. Bettahi I, Marker CL, Roman MI, Wickman K 2002 Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J Biol Chem 277:48282-48288 (Pubitemid 35470781)
15. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A 2011 Guidelines for the diagnosis and treatment of primary aldosteronism. The Japan Endocrine Society 2009. Endocr J 58:711-721
16. Adachi J, Hirai Y, Terui K, Nakano T, Fukuda Y, Suda T, Sasano H2003 A report of 7 cases of adrenal tumors secreting both cortisol and aldosterone. Intern Med 42:714-718 (Pubitemid 37021206)
17. Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, Izumiyama H, Sasano H, Hirata Y 2011 Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome. Endocr J 58:543-551
18. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM 2008 The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 93:1526-1540 (Pubitemid 351656485)
19. Algeciras-Schimnich A, Preissner CM, Young Jr WF, Singh RJ, Grebe SK 2008 Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 93:91-95
20. Sawka AM, Jaeschke R, Singh RJ, Young Jr WF 2003 A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88:553-558 (Pubitemid 36207789)
21. Honda S, Araki Y, Takahashi M, Kakehi K 1983 Spectrofluorimetric determination of catecholamines with 2-cyanoacetamide. Anal Chim Acta 149:297-303 (Pubitemid 13054871)
22. Shoup RE, Kissinger PT 1977 Determination of urinary normetanephrine, metanephrine, and 3-methoxytyramine by liquid chromatography, with amperometric detection. Clin Chem 23:1268-1274 (Pubitemid 8110456)
23. Yoshimura M, Komori T, Nakanishi T, Takahashi H 1993 Estimation of sulphoconjugated catecholamine concentrations in plasma by high-performance liquid chromatography. Ann Clin Biochem 30:135-141 (Pubitemid 23096589)
24. Ishida E, Yamada M, Horiguchi K, Taguchi R, Ozawa A, Shibusawa N, Hashimoto K, Satoh T, Yoshida S, Tanaka Y, Yokota M, Tosaka M, Hirato J, Yamada S, Yoshimoto Y, Mori M 2011 Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor. Endocr J 58:287-296
25. Horiguchi K, Yamada M, Satoh T, Hashimoto K, Hirato J, Tosaka M, Yamada S, Mori M 2009 Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue. Clin Cancer Res 15:2620-2629
26. He C, Yan X, Zhang H, Mirshahi T, Jin T, Huang A, Logothetis DE 2002 Identification of critical residues controlling G protein-gated inwardly rectifying K(+) channel activity through interactions with the βγ subunits of G proteins. J Biol Chem 277:6088-6096 (Pubitemid 34968395)
27. Funder JW 2011 Medicine. The genetics of primary aldosteronism. Science 331:685-686